| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A new endoscopic paradigm: evaluating the EASE-CD score for Crohn's disease
|
Bouhnik, Yoram
|
|
|
10 |
8 |
p. 705-706
|
article
|
| 2 |
Clinical success after peroral endoscopic myotomy in the context of reflux-related symptoms
|
Shiratori, Yasutoshi
|
|
|
10 |
8 |
p. 710
|
article
|
| 3 |
Correction to Lancet Gastroenterol Hepatol 2024; 9: 415–27
|
|
|
|
10 |
8 |
p. e10
|
article
|
| 4 |
Correction to Lancet Gastroenterol Hepatol 2025; 10: 715–25
|
|
|
|
10 |
8 |
p. e10
|
article
|
| 5 |
Development and validation of a novel Endoscopic ulcer Activity Score for Evaluation of Crohn's Disease (EASE-CD) using data from two randomised controlled trials
|
Ma, Christopher
|
|
|
10 |
8 |
p. 746-756
|
article
|
| 6 |
Efimosfermin alfa (BOS-580), a long-acting FGF21 analogue, in participants with phenotypic metabolic dysfunction-associated steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2a trial
|
Loomba, Rohit
|
|
|
10 |
8 |
p. 734-745
|
article
|
| 7 |
Exercise for colon cancer: from supportive care to therapy
|
The Lancet Gastroenterology & Hepatology,
|
|
|
10 |
8 |
p. 701
|
article
|
| 8 |
Faecal incontinence core outcome set: an international Delphi consensus exercise among patients, health-care professionals, and researchers
|
Assmann, Sadé L
|
|
|
10 |
8 |
p. 769-778
|
article
|
| 9 |
GLP-1 receptor agonists in alcohol use disorder and alcohol-associated liver disease
|
Singal, Ashwani K
|
|
|
10 |
8 |
p. 707-709
|
article
|
| 10 |
Isolated perianal Crohn's disease: a systematic review and expert consensus proposing novel diagnostic criteria and management advice
|
Hanna, Luke Nathan
|
|
|
10 |
8 |
p. 757-768
|
article
|
| 11 |
Pre-emptive TIPS for gastric variceal bleeding: an important first step but a long way to go
|
Praktiknjo, Michael
|
|
|
10 |
8 |
p. 703-705
|
article
|
| 12 |
Pre-emptive TIPS for gastric variceal bleeding in patients with cirrhosis (GAVAPROSEC): an open-label randomised clinical trial
|
Cervoni, Jean-Paul
|
|
|
10 |
8 |
p. 726-733
|
article
|
| 13 |
Research in Brief
|
Baker, Holly
|
|
|
10 |
8 |
p. 713
|
article
|
| 14 |
Safety and efficacy of the anti-TL1A monoclonal antibody tulisokibart for Crohn's disease: a phase 2a induction trial
|
Feagan, Brian G
|
|
|
10 |
8 |
p. 715-725
|
article
|
| 15 |
Standardising HBV nomenclature: a call to action from the HBV Forum
|
Wang, Su
|
|
|
10 |
8 |
p. 710-712
|
article
|
| 16 |
Tulisokibart shows promise for Crohn's disease
|
Lindsay, James
|
|
|
10 |
8 |
p. 702-703
|
article
|
| 17 |
Uptick of food allergies in recent years—real or epiphenomenon?
|
Venter, Carina
|
|
|
10 |
8 |
p. 714
|
article
|
Journal description